205 related articles for article (PubMed ID: 15946544)
1. [Reversal effect of haloperidol on doxorubicin resistance and chloride channel inhibition in erythroleukemic cell K562/Dox].
Zhou JH; Wu DZ
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):81-5. PubMed ID: 15946544
[TBL] [Abstract][Full Text] [Related]
2. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].
Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032
[TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
4. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
5. [Modulation of multiple drug resistance by nomegestrol acetate and droloxifene in K562/A02].
Li J; Xu L; He K
Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):288-91. PubMed ID: 11721384
[TBL] [Abstract][Full Text] [Related]
6. Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin.
Xue C; Wang C; Liu Q; Meng Q; Sun H; Huo X; Ma X; Liu Z; Ma X; Peng J; Liu K
Tumour Biol; 2016 Jul; 37(7):8587-97. PubMed ID: 26733176
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
8. [Reversal effect of sodium selenite on multidrug resistance in K562/ADR cell line and its mechanisms].
Cui J; Ding J; Wu YP; Liu FQ; Liu XC; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):756-61. PubMed ID: 17708798
[TBL] [Abstract][Full Text] [Related]
9. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTĪ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
10. [Reversal of multidrug resistance of K562/A02 cell line by mdr1 and GSTpi gene silence].
Gu JW; Zhang T; Chen BB; Lu Y; Lin GW
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):719-22. PubMed ID: 16620573
[TBL] [Abstract][Full Text] [Related]
11. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
12. [Study of mifepristone on reversing multidrug resistance of leukemic cell line K562/A02].
Kong DX; Chen CY; Xu FY; Jia JH
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):555-9. PubMed ID: 18078134
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyclosporine A, raloxifene and their combination on the reversion of multidrug resistance of K562/A02 line].
Bao W; Chen BA; Gao F; Ding JH; Xu WL; Sheng HL; Gao C; Sun YY; Chen J; Wang J; Zhao G; Ma Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):895-9. PubMed ID: 17096884
[TBL] [Abstract][Full Text] [Related]
14. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
[TBL] [Abstract][Full Text] [Related]
15. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.
Misra R; Sahoo SK
Mol Pharm; 2011 Jun; 8(3):852-66. PubMed ID: 21480667
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439
[TBL] [Abstract][Full Text] [Related]
18. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
Zheng Z; Aojula H; Clarke D
J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
[TBL] [Abstract][Full Text] [Related]
19. [Functional study of mdr1 and GSTpi expression reversed by hairpin siRNA in K562/A02 cell line].
Gu JW; Zhang T; Chen BB; Lu Y; Lin GW
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):17-20. PubMed ID: 16732933
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
